85. Improved Survival with Dual Immunomodulator Treatment of ARDS by blocking C5a and IL-6 Activity: Subanalysis from the PANAMO Study in Critically Ill COVID-19 Patients

Saved in:
Bibliographic Details
Published in:Open forum infectious diseases 2025-01, Vol.12 (Suppl 1)
Main Authors: Chemaly, Roy F, Vlaar, Alexander, Lim, Endry H T, Burnett, Bruce P, Chong, Camilla, Rückinger, simon, Zerbib, Robert, Panas, Raymond M, Guo, Renfeng, Riedemann, Niels, van de Beek, Diederik
Format: Article
Language:English
Subjects:
Oral Abstract
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue Suppl 1
container_start_page
container_title Open forum infectious diseases
container_volume 12
creator Chemaly, Roy F
Vlaar, Alexander
Lim, Endry H T
Burnett, Bruce P
Chong, Camilla
Rückinger, simon
Zerbib, Robert
Panas, Raymond M
Guo, Renfeng
Riedemann, Niels
van de Beek, Diederik
description
doi_str_mv 10.1093/ofid/ofae631.022
format article
fullrecord <record><control><sourceid>pubmedcentral</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11776636</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>pubmedcentral_primary_oai_pubmedcentral_nih_gov_11776636</sourcerecordid><originalsourceid>FETCH-pubmedcentral_primary_oai_pubmedcentral_nih_gov_117766363</originalsourceid><addsrcrecordid>eNqljU9Pg0AUxDcmJjbq3eP7AtRdCFC8GEI1kqhtbOOVPGBpn-6fZlkwfCU_pRy8ePYyM8lMfsPYjeBLwbPo1nbUzoIyicSSh-EZW4RRuApWWZxesOu-_-CcC8FjnmYL9r2Kl1Dqk7OjbGE3uJFGVPBF_gjrYU6l1oOx2raDQm8d7J1Er6XxYDvI39Y7qCeolW0-yRygiBHQtFA-BwnkjaeR_HQ3c2s0qKaeeuic1eCPErb5a_6ygZ0f2gnIQOHIU4NKTVAqBcXmvVwHIoMtepr_-it23qHq5fWvX7L7x4d98RSchlrLtpk3DlV1cqTRTZVFqv42ho7VwY6VEGmaJFES_Z_wA03eeoc</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>85. Improved Survival with Dual Immunomodulator Treatment of ARDS by blocking C5a and IL-6 Activity: Subanalysis from the PANAMO Study in Critically Ill COVID-19 Patients</title><source>Oxford Journals Open Access Collection</source><source>PubMed Central</source><creator>Chemaly, Roy F ; Vlaar, Alexander ; Lim, Endry H T ; Burnett, Bruce P ; Chong, Camilla ; Rückinger, simon ; Zerbib, Robert ; Panas, Raymond M ; Guo, Renfeng ; Riedemann, Niels ; van de Beek, Diederik</creator><creatorcontrib>Chemaly, Roy F ; Vlaar, Alexander ; Lim, Endry H T ; Burnett, Bruce P ; Chong, Camilla ; Rückinger, simon ; Zerbib, Robert ; Panas, Raymond M ; Guo, Renfeng ; Riedemann, Niels ; van de Beek, Diederik</creatorcontrib><identifier>EISSN: 2328-8957</identifier><identifier>DOI: 10.1093/ofid/ofae631.022</identifier><language>eng</language><publisher>US: Oxford University Press</publisher><subject>Oral Abstract</subject><ispartof>Open forum infectious diseases, 2025-01, Vol.12 (Suppl 1)</ispartof><rights>The Author(s) 2025. Published by Oxford University Press on behalf of Infectious Diseases Society of America. 2025</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11776636/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11776636/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids></links><search><creatorcontrib>Chemaly, Roy F</creatorcontrib><creatorcontrib>Vlaar, Alexander</creatorcontrib><creatorcontrib>Lim, Endry H T</creatorcontrib><creatorcontrib>Burnett, Bruce P</creatorcontrib><creatorcontrib>Chong, Camilla</creatorcontrib><creatorcontrib>Rückinger, simon</creatorcontrib><creatorcontrib>Zerbib, Robert</creatorcontrib><creatorcontrib>Panas, Raymond M</creatorcontrib><creatorcontrib>Guo, Renfeng</creatorcontrib><creatorcontrib>Riedemann, Niels</creatorcontrib><creatorcontrib>van de Beek, Diederik</creatorcontrib><title>85. Improved Survival with Dual Immunomodulator Treatment of ARDS by blocking C5a and IL-6 Activity: Subanalysis from the PANAMO Study in Critically Ill COVID-19 Patients</title><title>Open forum infectious diseases</title><subject>Oral Abstract</subject><issn>2328-8957</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2025</creationdate><recordtype>article</recordtype><recordid>eNqljU9Pg0AUxDcmJjbq3eP7AtRdCFC8GEI1kqhtbOOVPGBpn-6fZlkwfCU_pRy8ePYyM8lMfsPYjeBLwbPo1nbUzoIyicSSh-EZW4RRuApWWZxesOu-_-CcC8FjnmYL9r2Kl1Dqk7OjbGE3uJFGVPBF_gjrYU6l1oOx2raDQm8d7J1Er6XxYDvI39Y7qCeolW0-yRygiBHQtFA-BwnkjaeR_HQ3c2s0qKaeeuic1eCPErb5a_6ygZ0f2gnIQOHIU4NKTVAqBcXmvVwHIoMtepr_-it23qHq5fWvX7L7x4d98RSchlrLtpk3DlV1cqTRTZVFqv42ho7VwY6VEGmaJFES_Z_wA03eeoc</recordid><startdate>20250129</startdate><enddate>20250129</enddate><creator>Chemaly, Roy F</creator><creator>Vlaar, Alexander</creator><creator>Lim, Endry H T</creator><creator>Burnett, Bruce P</creator><creator>Chong, Camilla</creator><creator>Rückinger, simon</creator><creator>Zerbib, Robert</creator><creator>Panas, Raymond M</creator><creator>Guo, Renfeng</creator><creator>Riedemann, Niels</creator><creator>van de Beek, Diederik</creator><general>Oxford University Press</general><scope>5PM</scope></search><sort><creationdate>20250129</creationdate><title>85. Improved Survival with Dual Immunomodulator Treatment of ARDS by blocking C5a and IL-6 Activity: Subanalysis from the PANAMO Study in Critically Ill COVID-19 Patients</title><author>Chemaly, Roy F ; Vlaar, Alexander ; Lim, Endry H T ; Burnett, Bruce P ; Chong, Camilla ; Rückinger, simon ; Zerbib, Robert ; Panas, Raymond M ; Guo, Renfeng ; Riedemann, Niels ; van de Beek, Diederik</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-pubmedcentral_primary_oai_pubmedcentral_nih_gov_117766363</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2025</creationdate><topic>Oral Abstract</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chemaly, Roy F</creatorcontrib><creatorcontrib>Vlaar, Alexander</creatorcontrib><creatorcontrib>Lim, Endry H T</creatorcontrib><creatorcontrib>Burnett, Bruce P</creatorcontrib><creatorcontrib>Chong, Camilla</creatorcontrib><creatorcontrib>Rückinger, simon</creatorcontrib><creatorcontrib>Zerbib, Robert</creatorcontrib><creatorcontrib>Panas, Raymond M</creatorcontrib><creatorcontrib>Guo, Renfeng</creatorcontrib><creatorcontrib>Riedemann, Niels</creatorcontrib><creatorcontrib>van de Beek, Diederik</creatorcontrib><collection>PubMed Central (Full Participant titles)</collection><jtitle>Open forum infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chemaly, Roy F</au><au>Vlaar, Alexander</au><au>Lim, Endry H T</au><au>Burnett, Bruce P</au><au>Chong, Camilla</au><au>Rückinger, simon</au><au>Zerbib, Robert</au><au>Panas, Raymond M</au><au>Guo, Renfeng</au><au>Riedemann, Niels</au><au>van de Beek, Diederik</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>85. Improved Survival with Dual Immunomodulator Treatment of ARDS by blocking C5a and IL-6 Activity: Subanalysis from the PANAMO Study in Critically Ill COVID-19 Patients</atitle><jtitle>Open forum infectious diseases</jtitle><date>2025-01-29</date><risdate>2025</risdate><volume>12</volume><issue>Suppl 1</issue><eissn>2328-8957</eissn><cop>US</cop><pub>Oxford University Press</pub><doi>10.1093/ofid/ofae631.022</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier EISSN: 2328-8957
ispartof Open forum infectious diseases, 2025-01, Vol.12 (Suppl 1)
issn 2328-8957
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11776636
source Oxford Journals Open Access Collection; PubMed Central
subjects Oral Abstract
title 85. Improved Survival with Dual Immunomodulator Treatment of ARDS by blocking C5a and IL-6 Activity: Subanalysis from the PANAMO Study in Critically Ill COVID-19 Patients
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T15%3A02%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmedcentral&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=85.%20Improved%20Survival%20with%20Dual%20Immunomodulator%20Treatment%20of%20ARDS%20by%20blocking%20C5a%20and%20IL-6%20Activity:%20Subanalysis%20from%20the%20PANAMO%20Study%20in%20Critically%20Ill%20COVID-19%20Patients&rft.jtitle=Open%20forum%20infectious%20diseases&rft.au=Chemaly,%20Roy%20F&rft.date=2025-01-29&rft.volume=12&rft.issue=Suppl%201&rft.eissn=2328-8957&rft_id=info:doi/10.1093/ofid/ofae631.022&rft_dat=%3Cpubmedcentral%3Epubmedcentral_primary_oai_pubmedcentral_nih_gov_11776636%3C/pubmedcentral%3E%3Cgrp_id%3Ecdi_FETCH-pubmedcentral_primary_oai_pubmedcentral_nih_gov_117766363%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true